newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update

Trudhesa® Continues Strong Launch Trajectory with Q1 2022 TRx Growth of 111% vs. Q4 2021 Planned initiation of INP105 Proof-of-Concept Study for Autism Spectrum Disorder in 2Q 2022 Financing Agreement with Oaktree Capital Extends Cash Runway into